Stay updated on Elacestrant in ER+ Advanced Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Elacestrant in ER+ Advanced Breast Cancer Clinical Trial page.

Latest updates to the Elacestrant in ER+ Advanced Breast Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedThe page now shows a glossary toggle and new metadata fields such as 'Last Update Submitted that Met QC Criteria' and 'Last Update Posted', plus a 'No FEAR Act Data' item and a 'Revision: v3.4.0' note.SummaryDifference0.1%

- Check21 days agoChange DetectedThe page reflects Revision: v3.3.4 and removes Revision: v3.3.3, indicating a minor document revision. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check49 days agoChange DetectedExpanded the Locations section to include a comprehensive list of participating sites across numerous countries and U.S. states. This provides clearer visibility into where the study is conducted.SummaryDifference3%

- Check71 days agoChange DetectedThe page revision was updated from v3.3.1 to v3.3.2, with no changes to study details or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check78 days agoChange DetectedThe Publications section now states that publications are automatically filled from PubMed, and the revision label was updated from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check85 days agoChange DetectedRemoved the government funding status notice that warned information on the site may not be up to date and directed users to opm.gov and cc.nih.gov. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Elacestrant in ER+ Advanced Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elacestrant in ER+ Advanced Breast Cancer Clinical Trial page.